Advertisement

Etiological Factors in Cutaneous Carcinogenesis – An Introduction

  • Hermina C. Wisgerhof
  • Jan N. Bouwes Bavinck
Part of the Cancer Treatment and Research book series (CTAR, volume 146)

Risk factors for skin cancer in organ transplant recipients largely overlap with risk factors that are known in the nonimmunosuppressed population and consist of a complex interplay between environmental and host-related factors. Well-known environmental risk factors are exposure to sunlight [1-3], ionizing radiation [4-6], and various chemical carcinogens. Infections with certain viruses are also likely to be involved in skin cancer carcinogenesis.

Keywords

Human Leukocyte Antigen Skin Cancer Basal Cell Carcinoma Renal Transplant Recipient Human Leukocyte Antigen Class 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bouwes Bavinck JN, Hardie DR, Green A, Cutmore S, MacNaught A, O’Sullivan B, Siskind V, Van Der Woude FJ, Hardie IR. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996; 61:715–721.PubMedCrossRefGoogle Scholar
  2. 2.
    Boyle J, MacKie RM, Briggs JD, Junor BJ, Aitchison TC. Cancer, warts, and sunshine in renal transplant patients. A case-control study. Lancet 1984; 1:702–705.PubMedCrossRefGoogle Scholar
  3. 3.
    Kennedy C, Bajdik CD, Willemze R, de Gruijl FR, Bouwes Bavinck JN. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. J Invest Dermatol 2003; 120:1087–1093.PubMedCrossRefGoogle Scholar
  4. 4.
    Karagas MR, McDonald JA, Greenberg ER, Stukel TA, Weiss JE, Baron JA, Stevens MM. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group. J Natl Cancer Inst 1996; 88:1848–1853.PubMedCrossRefGoogle Scholar
  5. 5.
    Lichter MD, Karagas MR, Mott LA, Spencer SK, Stukel TA, Greenberg ER. Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group. Arch Dermatol 2000; 136:1007–1011.Google Scholar
  6. 6.
    Yoshinaga S, Hauptmann M, Sigurdson AJ, Doody MM, Freedman DM, Alexander BH, Linet MS, Ron E, Mabuchi K. Nonmelanoma skin cancer in relation to ionizing radiation exposure among U.S. radiologic technologists. Int J Cancer 2005; 115:828–834.PubMedCrossRefGoogle Scholar
  7. 7.
    Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 1994; 266:1865–1869.PubMedCrossRefGoogle Scholar
  8. 8.
    Dictor M, Rambech E, Way D, Witte M, Bendsoe N. Human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus) DNA in Kaposi’s sarcoma lesions, AIDS Kaposi’s sarcoma cell lines, endothelial Kaposi’s sarcoma simulators, and the skin of immunosuppressed patients. Am J Pathol 1996; 148:2009–2016.PubMedGoogle Scholar
  9. 9.
    Nickoloff BJ, Foreman KE. Etiology and pathogenesis of Kaposi’s sarcoma. Recent Results Cancer Res 2002; 160:332–342.PubMedGoogle Scholar
  10. 10.
    Baird PJ. Serological evidence for the association of papillomavirus and cervical neoplasia. Lancet 1983; 2:17–18.PubMedCrossRefGoogle Scholar
  11. 11.
    Meanwell CA, Cox MF, Blackledge G, Maitland NJ. HPV 16 DNA in normal and malignant cervical epithelium: implications for the aetiology and behaviour of cervical neoplasia. Lancet 1987; 1:703–707.PubMedCrossRefGoogle Scholar
  12. 12.
    Pfister H. The role of human papillomavirus in anogenital cancer. Obstet Gynecol Clin N Am 1996; 23:579–595.Google Scholar
  13. 13.
    Bouwes Bavinck JN, Feltkamp M, Struijk L, ter Schegget J. Human papillomavirus infection and skin cancer risk in organ transplant recipients. J Invest Dermatol Symp Proc 2001; 6:207–211.CrossRefGoogle Scholar
  14. 14.
    Euvrard S, Chardonnet Y, Pouteil-Noble CP, Kanitakis J, Thivolet J, Touraine JL. Skin malignancies and human papillomaviruses in renal transplant recipients. Transplant Proc 1993; 25:1392–1393.PubMedGoogle Scholar
  15. 15.
    Harwood CA, Surentheran T, McGregor JM, Spink PJ, Leigh IM, Breuer J, Proby CM. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000; 61:289–297.PubMedCrossRefGoogle Scholar
  16. 16.
    Pfister H, ter Schegget J. Role of HPV in cutaneous premalignant and malignant tumors. Clin Dermatol 1997; 15:335–347.PubMedCrossRefGoogle Scholar
  17. 17.
    Blohme I, Larko O. Premalignant and malignant skin lesions in renal transplant patients. Transplantation 1984; 37:165–167.PubMedGoogle Scholar
  18. 18.
    Giles GG, Marks R, Foley P. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J (Clin Res Ed) 1988; 296:13–17.CrossRefGoogle Scholar
  19. 19.
    Green A, Beardmore G, Hart V, Leslie D, Marks R, Staines D. Skin cancer in a Queensland population. J Am Acad Dermatol 1988; 19:1045–1052.PubMedCrossRefGoogle Scholar
  20. 20.
    Fortina AB, Piaserico S, Caforio AL, Abeni D, Alaibac M, Angelini A, Iliceto S, Peserico A. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol 2004; 140:1079–1085.PubMedCrossRefGoogle Scholar
  21. 21.
    Ramsay HM, Fryer AA, Hawley CM, Smith AG, Nicol DL, Harden PN. Factors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia. J Am Acad Dermatol 2003; 49:397–406.PubMedCrossRefGoogle Scholar
  22. 22.
    Han J, Kraft P, Colditz GA, Wong J, Hunter DJ. Melanocortin 1 receptor variants and skin cancer risk. Int J Cancer 2006; 119:1976–1984.PubMedCrossRefGoogle Scholar
  23. 23.
    Box NF, Duffy DL, Irving RE, Russell A, Chen W, Griffyths LR, Parsons PG, Green AC, Sturm RA. Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J Invest Dermatol 2001; 116:224–229.PubMedCrossRefGoogle Scholar
  24. 24.
    Healy E, Flannagan N, Ray A, Todd C, Jackson IJ, Matthews JN, Birch-Machin MA, Rees JL. Melanocortin-1-receptor gene and sun sensitivity in individuals without red hair. Lancet 2000; 355:1072–1073.PubMedCrossRefGoogle Scholar
  25. 25.
    Queille S, Luron L, Spatz A, Avril MF, Ribrag V, Duvillard P, Hiesse C, Sarasin A, Armand JP, Daya-Grosjean L. Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene. Carcinogenesis 2007; 28:724–731.PubMedCrossRefGoogle Scholar
  26. 26.
    Daya-Grosjean L, Robert C, Drougard C, Suarez H, Sarasin A. High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients. Cancer Res 1993; 53:1625–1629.PubMedGoogle Scholar
  27. 27.
    Rebel H, Kram N, Westerman A, Banus S, van Kranen HJ, de Gruijl FR. Relationship between UV-induced mutant p53 patches and skin tumours, analysed by mutation spectra and by induction kinetics in various DNA-repair-deficient mice. Carcinogenesis 2005; 26:2123–2130.PubMedCrossRefGoogle Scholar
  28. 28.
    Dunn DS, Inoko H, Kulski JK. The association between non-melanoma skin cancer and a young dimorphic Alu element within the major histocompatibility complex class I genomic region. Tissue Antigens 2006; 68:127–134.PubMedCrossRefGoogle Scholar
  29. 29.
    Liu B, Park E, Zhu F, Bustos T, Liu J, Shen J, Fischer SM, Hu Y. A critical role for I kappaB kinase alpha in the development of human and mouse squamous cell carcinomas. Proc Natl Acad Sci U S A 2006; 103:17202–17207.PubMedCrossRefGoogle Scholar
  30. 30.
    Aziz MH, Manoharan HT, Verma AK. Protein kinase C epsilon, which sensitizes skin to sun’s UV radiation-induced cutaneous damage and development of squamous cell carcinomas, associates with Stat3. Cancer Res 2007; 67:1385–1394.PubMedCrossRefGoogle Scholar
  31. 31.
    Hardie IR, Strong RW, Hartley LC, Woodruff PW, Clunie GJ. Skin cancer in Caucasian renal allograft recipients living in a subtropical climate. Surgery 1980; 87:177–183.PubMedGoogle Scholar
  32. 32.
    Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990; 49:506–509.PubMedCrossRefGoogle Scholar
  33. 33.
    Bock A, Bliss RL, Matas A, Little JA. Human leukocyte antigen type as a risk factor for nonmelanomatous skin cancer in patients after renal transplantation. Transplantation 2004; 78:775–778.PubMedCrossRefGoogle Scholar
  34. 34.
    Bouwes Bavinck JN, Kootte AM, Van Der Woude FJ, Vandenbroucke JP, Vermeer BJ, Claas FH. On a possible protective effect of HLA-A11 against skin cancer and keratotic skin lesions in renal transplant recipients. J Invest Dermatol 1991; 97:269–272.PubMedCrossRefGoogle Scholar
  35. 35.
    Bouwes Bavinck JN, Vermeer BJ, Van Der Woude FJ, Vandenbroucke JP, Schreuder GM, Thorogood J, Persijn GG, Claas FH. Relation between skin cancer and HLA antigens in renal-transplant recipients. N Engl J Med 1991; 325:843–848.PubMedCrossRefGoogle Scholar
  36. 36.
    Bouwes Bavinck JN, Claas FH, Hardie DR, Green A, Vermeer BJ, Hardie IR. Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia. J Invest Dermatol 1997; 108:708–711.PubMedCrossRefGoogle Scholar
  37. 37.
    Czarnecki D, Watkins F, Leahy S, Dyall-Smith D, Levis A, Nicholson I, Tait B. Skin cancers and HLA frequencies in renal transplant recipients. Dermatology 1992; 185:9–11.PubMedCrossRefGoogle Scholar
  38. 38.
    Glover MT, Bodmer J, Bodmer W, Kennedy LJ, Brown J, Navarrete C, Kwan JT, Leigh IM. HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer. Eur J Cancer 1993; 29A:520–524.PubMedCrossRefGoogle Scholar
  39. 39.
    Dyall-Smith D, Ross JB. Cutaneous malignancies in renal transplant recipients from Nova Scotia, Canada. Aust J Dermatol 1995; 36:79–82.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Hermina C. Wisgerhof
    • 1
  • Jan N. Bouwes Bavinck
    • 1
  1. 1.Department of DermatologyLeiden University Medical CenterThe Netherlands

Personalised recommendations